抑真菌剂相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
161	VIRAL AND FUNGAL INHIBITORS	PCT/US2009058039	2009-09-23	WO2010039534A2	2010-04-08	PADMANABHAN RADHAKRISHNAN; GROUTAS WILLIAM C
Novel classes of viral and fungal inhibitors are disclosed. These compounds are useful in treating, preventing, and/or ameliorating viral infections such as, for example, Hepatitis C Virus, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus, and fungal infections such as, for example, candidiasis.
162	INHIBITORS OF FUNGAL INVASION	PCT/US2004011187	2004-04-12	WO2004092123A3	2005-05-19	TALLEY JOHN JEFFREY; FRETZEN ANGELIKA; ZIMMERMAN CRAIG; BARDEN TIMOTHY; YANG JING JING; MARTINEZ EDUARDO; MILNE G TODD; ETCHELL A CORDERO; CHRISTINE M PIERCE; HOUMAN FARIBA; BUSBY ROBERT; SUMMERS ERIC F; ANTONELLI STEPHEN; LEE PETER; FARWELL MICHAEL; MAYORGA MARIA; O'LEARY JESSICA
This invention relates to various anti-fungall agents including agents that are inhibitors of fungal invasion.
163	INHIBITORS OF FUNGAL INVASION	PCT/US0327911	2003-09-08	WO2004021997A8	2004-07-29	TALLEY JOHN JEFFREY; FRETZEN ANGELIKA; ZIMMERMAN CRAIG; BARDEN TIMOTHY; YANG JING JING; MARTINEZ EDUARDO; BUSBY ROBERT; CORDERO ETCHELL A; CIPRIANO FARIBA HOUMAN; PIERCE CHRISTINE M; SUMMERS ERIC F
This invention relates to isoxazole-based inhibitors of fungal invasion.
164	항구토제와 엔케팔리나제 억제제의 배합물	KR1020067016159	2005-02-14	KR1020060132691A	2006-12-21	슈워츠장샤를; 르꽁뜨잔느마리
The present invention concerns new combinations of an anti-emetic agent and an enkephalinase inhibitor, the uses of said combinations for treating diarrhea and/or gastroenteritis.
165	INHIBITORS OF FUNGAL INVASION	PCT/US0327911	2003-09-08	WO2004021997A2	2004-03-18	TALLEY JOHN JEFFREY; FRETZEN ANGELIKA; ZIMMERMAN CRAIG; BARDEN TIMOTHY; YANG JING JING; MARTINEZ EDUARDO; BUSBY ROBERT; CORDERO ETCHELL A; HOUMAN FARIBA; PIERCE CHRISTINE M; SUMMERS ERIC F
This invention relates to isoxazole-based inhibitors of fungal invasion.
166	FUNGAL GROWTH INHIBITORS	PCT/US1999/014835	1999-06-30	WO00001387A1	2000-01-13
Phosphodiesterase (PDE) inhibitors and their use as anti-fungal agents. The data suggesting these selective PDE inhibitors are capable of control fungal growth in plant and crop protection applications.
167	赤かび病菌かび毒産生抑制剤	JP2015160764	2015-08-18	JP2017039649A	2017-02-23	木村眞; 前田一行; 中嶋佑一; 長田裕之; 本山高幸; 斉藤臣雄; 近藤恭光
【課題】赤かび病菌のかび毒抑制剤及び赤かび病菌のかび毒抑制方法の提供。【解決手段】式(1)で表される化合物及び薬学的に許容される塩の少なくとも1つ以上を有効成分とする赤かび病菌のかび毒抑制剤、及び該抑制剤による赤かび病菌のかび毒産生を抑制する方法。 (R1は−COCH3、−OH、−COCH2OH又は−C≡C;R2は−H又は−OH;R3は−H又は−OH;R4はアミノ酸又はアミノ酸類縁体) 【選択図】図1
168	真菌増殖抑制剤	PCT/JP2007/052249	2007-02-08	WO2007091644A1	2007-08-16	西原達次; 秋房住郎
本発明によって、極めて安全でかつ有用な真菌増殖抑制剤等を提供される。具体的には、本発明によって、（１）ヒアルロン酸又はその塩（重金属塩を除く。）を有効成分とする真菌増殖抑制剤、及びヒアルロン酸又はその塩（重金属塩を除く。）と真菌とを接触させるステップを少なくとも含む真菌増殖抑制方法、（２）ヒアルロン酸合成酵素をコードするＤＮＡを有効成分とする細胞が有する真菌増殖抑制作用の増強剤、（３）ヒアルロン酸合成酵素をコードするＤＮＡを細胞に導入するステップを少なくとも含む細胞の真菌増殖抑制作用の増強方法、（４）ヒアルロン酸合成酵素をコードするＤＮＡが導入された細胞と真菌とを接触させるステップを少なくとも含む真菌増殖抑制方法が提供される。
169	INHIBITORS OF FUNGAL INVASION	PCT/US2004/011187	2004-04-12	WO2004092123A2	2004-10-28	TALLEY, John, Jeffrey; FRETZEN, Angelika; ZIMMERMAN, Craig; BARDEN, Timothy.; YANG, Jing, Jing; MARTINEZ, Eduardo; MILNE, G. Todd; ETCHELL, A. Cordero; CHRISTINE, M. Pierce; HOUMAN, Fariba; BUSBY, Robert; SUMMERS, Eric, F.; ANTONELLI, Stephen; LEE, Peter; FARWELL, Michael; MAYORGA, Maria; O'LEARY, Jessica
This invention relates to various anti-fungall agents including agents that are inhibitors of fungal invasion.
170	항혈소판제와 산 억제제를 포함하는 경구 투여 형태	KR1020157021344	2007-04-04	KR1020150105419A	2015-09-16	골드스미스,마크,에이.; 바다스,엘리자베스
본 명세서는 항혈소판제와 산 억제제를 포함하는 경구 투여 형태 뿐만 아니라 이러한 항혈소판제와 산 억제제를 사용하여 대상체를 치료하는 방법을 제공한다.
171	リパーゼ活性阻害剤、抗真菌剤、及びフケ抑制剤	JP2012126937	2012-06-04	JP5925605B2	2016-05-25	滝川博文; 佐藤紀子

172	ENDOPARASITICIDAL AND ECTOPARASITICIDAL AGENTS	US09331040	1999-06-15	US20030055089A1	2003-03-20	KIRKOR SIRINYAN; HUBERT DORN; KIRSTEN HEESCHEN; ULRICH HEUKAMP; RICHARD KUJANEK
The present invention relates to mixtures of avermectins, 22,23-dihydroavermectin B1 (ivermectin) and milbemycins from the class of the macrocyclic lactones with agonists or antagonists of the nicotinergic acetylcholine receptors of insects, if appropriate in the presence of other active compounds and diluents or excipients.
173	항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물	KR1020087026891	2007-04-04	KR1020080112361A	2008-12-24	골드스미스,마크,에이.; 바다스,엘리자베스
The present disclosure provides oral dosage forms comprising an antiplatelet agent and an acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an acid inhibitor. ® KIPO & WIPO 2009
174	Alkylated naphthalene fungal growth inhibitors	US16797462	1962-01-22	US3080278A	1963-03-05	DOUROS JR JOHN D; RAYMOND RICHARD L; MELCHIORE JOHN J

175	Methods for the identification of fungal glucose utilization inhibitors and antifungal agents	US09927734	2001-08-10	US06743598B2	2004-06-01	Claude P. Selitrennikoff; Mitsunori Nakata
The present invention provides methods for simultaneously assessing microbial phosphoglucose isomerase, ketol-isomerase and glucosamine-6-phosphate acetyltransferase activities, by measuring the production of Coenzyme A (CoA). The present invention finds use in the isolation of new classes of antifungal drugs, wherein the compounds have the ability to inhibit fungal glucose utilization.
176	ＱＯ 저해제에 대해 내성을 갖는 식물병원성 진균 방제를 위한 스트로빌루린형 화합물의 용도	KR1020147020070	2012-12-06	KR1020140107510A	2014-09-04	라인하이머요아힘; 테르테리안피올레타; 레들리히슈테판; 크렘초브도리스; 로젠바움클라우디아; 롤러세바슈티안게오르기오스; 그람메노스바실리오스; 필거크리슈티안; 뢸프란츠; 게베어마르쿠스; 슈탐러게르트; 몬타크유리트; 자우터후베르트
본 발명은 Qo 저해제에 대한 내성을 부여하는 미토콘드리아 시토크롬 b 유전자에서의 돌연변이를 포함하는 식물병원성 진균의 방제를 위한 식 I 의 스트로빌루린형 화합물 및 이의 N-산화물 및 염의 용도, 및 이러한 진균 방제를 위한 방법에 관한 것이다. 본 발명은 또한 신규한 화합물, 이들 화합물 제조 공정, 하나 이상의 이러한 화합물을 포함하는 조성물, 식물 검역 적용, 및 하나 이상의 이러한 화합물로 코팅된 종자에 관한 것이다.
177	Methods for the identification of fungal glucose utilization inhibitors and antifungal agents	US09927734	2001-08-10	US20030194758A1	2003-10-16	Claude P. Selitrennikoff; Mitsunori Nakata
The present invention provides methods for simultaneously assessing microbial phosphoglucose isomerase, ketol-isomerase and glucosamine-6-phosphate acetyltransferase activities, by measuring the production of Coenzyme A (CoA). The present invention finds use in the isolation of new classes of antifungal drugs, wherein the compounds have the ability to inhibit fungal glucose utilization.
178	Antifungal agent, mold remover detergent, resin having antifungal effect, and mold suppression method	JP2006286859	2006-10-20	JP2008100971A	2008-05-01	MATSUMOTO TATSUJI; MIKAMI TAKESHI; WATABE TOSHIHIKO; OGASAWARA AYAKO; MISAWA YOSHITOMO
PROBLEM TO BE SOLVED: To provide an inexpensive antifungal agent, a resin having an antifungal effect, and a mold suppression method, which is effective against black molds growing in a bathroom, lavatory, etc., is biologically safe and does not damage fabrics such as clothes. SOLUTION: Cysteine is used as an active ingredient imparting an antifungal effect. Propagation of molds can be prevented or controlled by mixing cysteine with the antifungal agent, a mold remover detergent, the resin, etc. and applying them to a moldy area. The antifungal agent, the mold remover detergent, the resin, etc. comprising cysteine are preferably used against molds belonging to genera Cladosporium, Alternaria, or Aureobasidium. COPYRIGHT: (C)2008,JPO&INPIT
179	Composition for use as a fungistat and for the treatment of fungal infections	US798030	1997-02-06	US5760052A	1998-06-02	Robert Peacock
A composition for use as a fungistat for the treatment and prevention of infections such as sporotrichosis, onychomycosis infections, white line disease, hoof rot, jungle rot, pseudallecheria boydii, scopulariopsis, athletes foot, canker sole and fungal infections generally. The fungistat composition includes acriflavine and gentian violet.
180	レニン阻害剤、キマーゼ阻害剤又は降圧剤、並びにレニン阻害活性及び/又はキマーゼ阻害活性を有する食品	JP2014019845	2014-02-04	JP2015147736A	2015-08-20	韮澤悟; 程永強; 高橋砂織
【課題】スルカリア・スルカタ又はロバリア・クロカワエ由来のレニン阻害活性、キマーゼ阻害活性及び降圧剤を提供することにある。【解決手段】スルカリア・スルカタ又はロバリア・クロカワエ、又はスルカリア・スルカタの抽出物又はロバリア・クロカワエの抽出物を含有するレニン阻害活性、キマーゼ阻害活性及び降圧剤。【選択図】なし

4 5 6 7 8 9 10 11 12 13

IPRDB

热门服务

关于我们

友情链接

联系方式